Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Direxion Daily S&P 500 Bull 3X Shares (SPXL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Direxion Daily S&P 500 Bull 3X Shares — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.61 (market cap $2.27B), while Direxion Daily S&P 500 Bull 3X Shares trades at $296.99 (market cap $7.36B). The key difference: Direxion Daily S&P 500 Bull 3X Shares is far larger — about 3.2× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Direxion Daily S&P 500 Bull 3X Shares is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| SLS | SPXL | |
|---|---|---|
Market Cap | $2.27B | $7.36B |
Volume | 4,179,659 | 1,835,467 |
Sector | Health | Leveraged / Inverse |
52-Week High | $15.46 | $301.38 |
52-Week Low | $1.39 | $170.20 |
Enterprise Value | $2.14B | — |
Typical Hold Time | — | 32 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPXL trades at $296.84, down 0.79% on the day, with technical indicators showing a bullish trend supported by moving averages. The ETF maintains neutral oscillator signals while approaching key resistance at $299. Recent market sentiment reflects mixed outlooks for S&P 500 performance amid earnings growth concerns and seasonal patterns.
The leveraged ETF's performance remains tied to S&P 500 movements, with Wall Street projecting potential upside but facing headwinds from expected earnings growth slowdown. Key risks include market concentration in top holdings and geopolitical uncertainties affecting broader market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Direxion Daily S&P 500 Bull 3X Shares
SPXL aims for 300% of the S&P 500's daily performance. It uses swaps and futures to provide 3x leverage, making it a high-risk tool for short-term traders. Due to daily resets, it is prone to volatility decay and is not intended for long-term holding.
Read more on SPXL →
